ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI)

A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology

Ralph G. Brindis, Pamela S. Douglas, Robert C. Hendel, Eric D. Peterson, Michael J. Wolk, Joseph M. Allen, Manesh R. Patel, Ira E. Raskin, Robert C. Hendel, Timothy M. Bateman, Manuel D. Cerqueira, Raymond J Gibbons, Linda D. Gillam, John A. Gillespie, Robert C. Hendel, Ami E. Iskandrian, Scott D. Jerome, Harlan M. Krumholz, Joseph V. Messer, John A. Spertus & 1 others Stephen A. Stowers

Research output: Contribution to journalArticle

268 Citations (Scopus)

Abstract

Under the auspices of the American College of Cardiology Foundation (ACCF) and the American Society of Nuclear Cardiology (ASNC), an appropriateness review was conducted for radionuclide cardiovascular imaging (RNI), specifically gated single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI). The review assessed the risks and benefits of the imaging test for several indications or clinical scenarios and scored them based on a scale of 1 to 9, where the upper range (7 to 9) implies that the test is generally acceptable and is a reasonable approach, and the lower range (1 to 3) implies that the test is generally not acceptable and is not a reasonable approach. The mid range (4 to 6) implies that the test may be generally acceptable and may be a reasonable approach for the indication. The indications for this review were primarily drawn from existing clinical practice guidelines and modified based on discussion by the ACCF Appropriateness Criteria Working Group and the Technical Panel members who rated the indications. The method for this review was based on the RAND/UCLA approach for evaluating appropriateness, which blends scientific evidence and practice experience. A modified Delphi technique was used to obtain firstand second-round ratings of 52 clinical indications. The ratings were done by a Technical Panel with diverse membership, including nuclear cardiologists, referring physicians (including an echocardiographer), health services researchers, and a payer (chief medical officer). These results are expected to have a significant impact on physician decision making and performance, reimbursement policy, and future research directions. Periodic assessment and updating of criteria will be undertaken as needed.

Original languageEnglish (US)
Pages (from-to)1587-1605
Number of pages19
JournalJournal of the American College of Cardiology
Volume46
Issue number8
DOIs
StatePublished - Oct 18 2005

Fingerprint

Myocardial Perfusion Imaging
Single-Photon Emission-Computed Tomography
Cardiology
Regional Health Planning
Delphi Technique
Physicians
Practice Guidelines
Radionuclide Imaging
Health Services
Decision Making
Research Personnel
Direction compound
Cardiologists

ASJC Scopus subject areas

  • Nursing(all)

Cite this

ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI) : A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology. / Brindis, Ralph G.; Douglas, Pamela S.; Hendel, Robert C.; Peterson, Eric D.; Wolk, Michael J.; Allen, Joseph M.; Patel, Manesh R.; Raskin, Ira E.; Hendel, Robert C.; Bateman, Timothy M.; Cerqueira, Manuel D.; Gibbons, Raymond J; Gillam, Linda D.; Gillespie, John A.; Hendel, Robert C.; Iskandrian, Ami E.; Jerome, Scott D.; Krumholz, Harlan M.; Messer, Joseph V.; Spertus, John A.; Stowers, Stephen A.

In: Journal of the American College of Cardiology, Vol. 46, No. 8, 18.10.2005, p. 1587-1605.

Research output: Contribution to journalArticle

Brindis, RG, Douglas, PS, Hendel, RC, Peterson, ED, Wolk, MJ, Allen, JM, Patel, MR, Raskin, IE, Hendel, RC, Bateman, TM, Cerqueira, MD, Gibbons, RJ, Gillam, LD, Gillespie, JA, Hendel, RC, Iskandrian, AE, Jerome, SD, Krumholz, HM, Messer, JV, Spertus, JA & Stowers, SA 2005, 'ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology', Journal of the American College of Cardiology, vol. 46, no. 8, pp. 1587-1605. https://doi.org/10.1016/j.jacc.2005.08.029
Brindis, Ralph G. ; Douglas, Pamela S. ; Hendel, Robert C. ; Peterson, Eric D. ; Wolk, Michael J. ; Allen, Joseph M. ; Patel, Manesh R. ; Raskin, Ira E. ; Hendel, Robert C. ; Bateman, Timothy M. ; Cerqueira, Manuel D. ; Gibbons, Raymond J ; Gillam, Linda D. ; Gillespie, John A. ; Hendel, Robert C. ; Iskandrian, Ami E. ; Jerome, Scott D. ; Krumholz, Harlan M. ; Messer, Joseph V. ; Spertus, John A. ; Stowers, Stephen A. / ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI) : A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology. In: Journal of the American College of Cardiology. 2005 ; Vol. 46, No. 8. pp. 1587-1605.
@article{80673eb31e6349508436d8231e20c74d,
title = "ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology",
abstract = "Under the auspices of the American College of Cardiology Foundation (ACCF) and the American Society of Nuclear Cardiology (ASNC), an appropriateness review was conducted for radionuclide cardiovascular imaging (RNI), specifically gated single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI). The review assessed the risks and benefits of the imaging test for several indications or clinical scenarios and scored them based on a scale of 1 to 9, where the upper range (7 to 9) implies that the test is generally acceptable and is a reasonable approach, and the lower range (1 to 3) implies that the test is generally not acceptable and is not a reasonable approach. The mid range (4 to 6) implies that the test may be generally acceptable and may be a reasonable approach for the indication. The indications for this review were primarily drawn from existing clinical practice guidelines and modified based on discussion by the ACCF Appropriateness Criteria Working Group and the Technical Panel members who rated the indications. The method for this review was based on the RAND/UCLA approach for evaluating appropriateness, which blends scientific evidence and practice experience. A modified Delphi technique was used to obtain firstand second-round ratings of 52 clinical indications. The ratings were done by a Technical Panel with diverse membership, including nuclear cardiologists, referring physicians (including an echocardiographer), health services researchers, and a payer (chief medical officer). These results are expected to have a significant impact on physician decision making and performance, reimbursement policy, and future research directions. Periodic assessment and updating of criteria will be undertaken as needed.",
author = "Brindis, {Ralph G.} and Douglas, {Pamela S.} and Hendel, {Robert C.} and Peterson, {Eric D.} and Wolk, {Michael J.} and Allen, {Joseph M.} and Patel, {Manesh R.} and Raskin, {Ira E.} and Hendel, {Robert C.} and Bateman, {Timothy M.} and Cerqueira, {Manuel D.} and Gibbons, {Raymond J} and Gillam, {Linda D.} and Gillespie, {John A.} and Hendel, {Robert C.} and Iskandrian, {Ami E.} and Jerome, {Scott D.} and Krumholz, {Harlan M.} and Messer, {Joseph V.} and Spertus, {John A.} and Stowers, {Stephen A.}",
year = "2005",
month = "10",
day = "18",
doi = "10.1016/j.jacc.2005.08.029",
language = "English (US)",
volume = "46",
pages = "1587--1605",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "8",

}

TY - JOUR

T1 - ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI)

T2 - A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology

AU - Brindis, Ralph G.

AU - Douglas, Pamela S.

AU - Hendel, Robert C.

AU - Peterson, Eric D.

AU - Wolk, Michael J.

AU - Allen, Joseph M.

AU - Patel, Manesh R.

AU - Raskin, Ira E.

AU - Hendel, Robert C.

AU - Bateman, Timothy M.

AU - Cerqueira, Manuel D.

AU - Gibbons, Raymond J

AU - Gillam, Linda D.

AU - Gillespie, John A.

AU - Hendel, Robert C.

AU - Iskandrian, Ami E.

AU - Jerome, Scott D.

AU - Krumholz, Harlan M.

AU - Messer, Joseph V.

AU - Spertus, John A.

AU - Stowers, Stephen A.

PY - 2005/10/18

Y1 - 2005/10/18

N2 - Under the auspices of the American College of Cardiology Foundation (ACCF) and the American Society of Nuclear Cardiology (ASNC), an appropriateness review was conducted for radionuclide cardiovascular imaging (RNI), specifically gated single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI). The review assessed the risks and benefits of the imaging test for several indications or clinical scenarios and scored them based on a scale of 1 to 9, where the upper range (7 to 9) implies that the test is generally acceptable and is a reasonable approach, and the lower range (1 to 3) implies that the test is generally not acceptable and is not a reasonable approach. The mid range (4 to 6) implies that the test may be generally acceptable and may be a reasonable approach for the indication. The indications for this review were primarily drawn from existing clinical practice guidelines and modified based on discussion by the ACCF Appropriateness Criteria Working Group and the Technical Panel members who rated the indications. The method for this review was based on the RAND/UCLA approach for evaluating appropriateness, which blends scientific evidence and practice experience. A modified Delphi technique was used to obtain firstand second-round ratings of 52 clinical indications. The ratings were done by a Technical Panel with diverse membership, including nuclear cardiologists, referring physicians (including an echocardiographer), health services researchers, and a payer (chief medical officer). These results are expected to have a significant impact on physician decision making and performance, reimbursement policy, and future research directions. Periodic assessment and updating of criteria will be undertaken as needed.

AB - Under the auspices of the American College of Cardiology Foundation (ACCF) and the American Society of Nuclear Cardiology (ASNC), an appropriateness review was conducted for radionuclide cardiovascular imaging (RNI), specifically gated single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI). The review assessed the risks and benefits of the imaging test for several indications or clinical scenarios and scored them based on a scale of 1 to 9, where the upper range (7 to 9) implies that the test is generally acceptable and is a reasonable approach, and the lower range (1 to 3) implies that the test is generally not acceptable and is not a reasonable approach. The mid range (4 to 6) implies that the test may be generally acceptable and may be a reasonable approach for the indication. The indications for this review were primarily drawn from existing clinical practice guidelines and modified based on discussion by the ACCF Appropriateness Criteria Working Group and the Technical Panel members who rated the indications. The method for this review was based on the RAND/UCLA approach for evaluating appropriateness, which blends scientific evidence and practice experience. A modified Delphi technique was used to obtain firstand second-round ratings of 52 clinical indications. The ratings were done by a Technical Panel with diverse membership, including nuclear cardiologists, referring physicians (including an echocardiographer), health services researchers, and a payer (chief medical officer). These results are expected to have a significant impact on physician decision making and performance, reimbursement policy, and future research directions. Periodic assessment and updating of criteria will be undertaken as needed.

UR - http://www.scopus.com/inward/record.url?scp=26844552946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26844552946&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2005.08.029

DO - 10.1016/j.jacc.2005.08.029

M3 - Article

VL - 46

SP - 1587

EP - 1605

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 8

ER -